Premier Alternatives

Pharmazz

Willowbrook, IL · Founded 2010 · Privately Held (backing)

Operator of a pharmaceutical company intended to focus on discovering, acquiring, developing, and commercializing therapeutics. Pharmazz is based in Willowbrook, IL and was founded in 2010. It was valued at $588 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $45.8 million across 8 recorded rounds; the latest was a $10 million early-stage round in May 2025.

PMV mark · valuation
$588.0M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$45.8M
Last round
Early Stage VC
May 2025

Pharmazz key facts

as of Oct 2026
  • Operator of a pharmaceutical company intended to focus on discovering, acquiring, developing, and commercializing therapeutics.
  • Pharmazz is valued at approximately $588.0M as of Oct 2026, set at its later-stage round, Jun 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $45.8M across 8 recorded rounds; the latest was Early Stage VC ($10.0M) in May 2025.
  • Notable investors include Keiretsu Forum, Lung, National Heart, Sun Pharmaceutical Industries, and Blood Institute.
  • Pharmazz has filed 12 Form Ds with the SEC since 2018, most recently Jun 2025 ($10.0M sold to 1 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$588.0M

Valued at $588.0M at its later-stage round, Jun 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Pharmazz with a free account
  • ·Watch Pharmazz: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Pharmazz funding rounds

8 rounds
May 2025Early Stage VC$10.0MSEC filing▮
Aug 2024Early Stage VC$7.5MSEC filing▮
Oct 2023Seed Round$450KSEC filing▮
Oct 2022Seed Round$2.3MSEC filing▮
Apr 2021Early Stage VC$5.5MSEC filing▮
Full funding history →

Pharmazz valuation

Pharmazz was valued at $588 million at its later-stage round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Pharmazz raised?

Pharmazz has raised $45.8 million across 8 recorded rounds since 2018. The largest was a $7.5 million early-stage round in Aug 2024; the most recent was a $10 million early-stage round in May 2025.

Pharmazz has filed 12 Form Ds with the SEC since 2018, most recently in Jun 2025 ($10 million sold to 1 investor).

Pharmazz investors

5 investors are on record for Pharmazz, including Keiretsu Forum, Lung, National Heart and Sun Pharmaceutical Industries. The early-stage round in May 2025 drew 1 investor.

About Pharmazz

Operator of a pharmaceutical company intended to focus on discovering, acquiring, developing, and commercializing therapeutics. The company's products include therapeutics for hypovolemic shock, postoperative pain, cardiac arrest, Alzheimer's disease, ischemic stroke, spinal cord injury, tumour diagnosis, diabetic ketoacidosis, and opioid tolerance, enabling hospitals to avail products for the diagnosis and treatment of clinical conditions that require critical care and hospital settings.

Sector
Healthcare
HQ
Willowbrook, IL, United States
Founded
2010
Employees
44
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.